Patientsʼ Willingness to Accept the Risks and Benefits of New Treatments for Chronic Hepatitis C Virus Infection

Patient - United States
doi 10.2165/11633580-000000000-00000
Full Text
Abstract

Available in full text

Categories
Nursing
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Willingness to Pay and Accept Risks to Cure Chronic Disease.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1986English

Treatment Options for Chronic Hepatitis C Virus Infection

Medicinski Pregled
Medicine
2006English

Estimating Progression to Cirrhosis in Chronic Hepatitis C Virus Infection

Hepatology
MedicineHepatology
2001English

The Distribution of Hepatitis C Virus Genotypes in Patients With Chronic Hepatitis C Infection

Türk Mikrobiyoloji Cemiyeti Dergisi
2016English

Boceprevir in the Treatment of Chronic Hepatitis C Virus Infection

Virus Adaptation and Treatment
VirologyInfectious DiseasesImmunology
2011English

Chronic Hepatitis C Virus Infection: A New Modifiable Cardio-Metabolic Risk Factor ?

Medicine and Pharmacy Reports
Medicine
2017English

Interleukin-6 Haplotypes and the Response to Therapy of Chronic Hepatitis C Virus Infection

Genes and Immunity
ImmunologyGenetics
2009English

Risk Factors for Hepatitis C Virus Infection in Canadian Patients With Chronic Type C Hepatitis

Canadian Journal of Gastroenterology
1995English

Chronic Hepatitis C Virus Infection: Everyone Should Be Treated

Clinical Liver Disease
Hepatology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy